# A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet

> **NCT03804671** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 730357
- **DRUG:** BI 730357 mixed with [C-14] BI 730357 BS

## Key facts

- **NCT ID:** NCT03804671
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-31
- **Primary completion:** 2019-03-26
- **Final completion:** 2019-03-26
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03804671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03804671, "A Study in Healthy Men to Measure the Amount of BI 730357 in the Blood When Taken as a Tablet". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03804671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*